AEPCX
Price
$62.33
Change
-$0.26 (-0.42%)
Updated
Oct 17 closing price
Net Assets
137.06B
FSOSX
Price
$16.16
Change
-$0.02 (-0.12%)
Updated
Oct 17 closing price
Net Assets
15.9B
Interact to see
Advertisement

AEPCX vs FSOSX

Header iconAEPCX vs FSOSX Comparison
Open Charts AEPCX vs FSOSXBanner chart's image
American Funds EUPAC C
Price$62.33
Change-$0.26 (-0.42%)
VolumeN/A
Net Assets137.06B
Fidelity Series Overseas
Price$16.16
Change-$0.02 (-0.12%)
VolumeN/A
Net Assets15.9B
AEPCX vs FSOSX Comparison Chart in %
View a ticker or compare two or three
VS
AEPCX vs. FSOSX commentary
Oct 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AEPCX is a Buy and FSOSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
AEPCX has more cash in the bank: 137B vs. FSOSX (15.9B). FSOSX pays higher dividends than AEPCX: FSOSX (1.87) vs AEPCX (0.16). AEPCX was incepted earlier than FSOSX: AEPCX (25 years) vs FSOSX (6 years). AEPCX (1.57) is less costly to investors than FSOSX (0.01). FSOSX (36.00) and AEPCX (35.00) have comparable annual turnover. FSOSX has a lower initial minimum investment than AEPCX: FSOSX (0) vs AEPCX (250). FSOSX annual gain was more profitable for investors over the last year : 12.62 vs. AEPCX (10.02). FSOSX return over 5 years is better than : 53.88 vs. AEPCX (9.92).
AEPCXFSOSXAEPCX / FSOSX
Total Expense Ratio1.570.0115,700%
Annual Report Gross Expense Ratio1.570.0115,700%
Fund Existence25 years6 years-
Gain YTD20.63120.238102%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets137B15.9B862%
Annual Yield % from dividends0.161.878%
Returns for 1 year10.0212.6279%
Returns for 3 years45.8573.6962%
Returns for 5 years9.9253.8818%
Returns for 10 years36.76N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CIGI157.623.03
+1.96%
Colliers International Group
NTRSO20.000.04
+0.20%
Northern Trust Corp
BRNS1.33-0.02
-1.33%
Barinthus Biotherapeutics plc
JANX26.76-0.44
-1.62%
Janux Therapeutics
NVEC71.97-1.42
-1.93%
NVE Corp